Cadiot-Chodkiewicz coupling
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
The Cadiot-Chodkiewicz coupling in organic chemistry is a coupling reaction between a terminal alkyne and a haloalkyne catalyzed by a copper(I) salt such as copper(I) bromide and an amine base [1] [1]. The reaction product is a di-acetylene or di-alkyne.
The reaction mechanism involves deprotonation by base of the acetylenic proton followed by formation of a copper(I) acetylide. A cycle of oxidative addition and reductive elimination on the copper center then creates a new carbon carbon bond.
Related couplings are the Glaser coupling and the Eglinton coupling.
Cadiot-Chodkiewicz coupling
In one study [1] the Cadiot-Chodkiewicz coupling has been applied in the synthesis of acetylene macrocycles starting from cis-1,4-diethynyl-1,4-dimethoxycyclohexa-2,5-diene. This compound is also the starting material for the dibromide through NBS and silver nitrate:
The coupling reaction itself takes place in methanol with piperidine, the hydrochloric acid salt of hydroxylamine and copper(I) bromide.
Eglinton reaction
In the related Eglinton reaction [1] two terminal alkynes are coupled directly a copper(II) salt such as cupric acetate. This procedure was used in the synthesis of cyclooctadecanonaene. Another example is the synthesis of diphenyldiacetylene from phenylacetylene [1]
Glaser coupling
The Glaser coupling (1870) is by far the oldest acetylenic coupling and is based on cuprous salts like copper(I) bromide and an additional oxidant like oxygen. The base in its original scope is ammonia [1][1].
Hay coupling
The Hay coupling (1962) is another version of the Glaser coupling with the TMEDA complex if copper(I) chloride [1].An example is the the coupling of trimethylsilylacetylene [1]
References
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
